Recurrent chromosomal alterations in molecularly classified AIDS-related lymphomas: An integrated analysis of DNA copy number and gene expression

Journal of Acquired Immune Deficiency Syndromes

Volumn 54, Issue 1, 2010, Pages 18-26

  Deffenbacher, Karen E ^a   Iqbal, Javeed ^a   Liu, Zhongfeng ^a   Fu, Kai ^a   Chan, Wing C ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

AIDS related lymphoma; Array based comparative genomic hybridization; Burkitt lymphoma; Diffuse Large B Cell lymphoma; Gene expression profiling

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CHROMOSOME 16Q; CHROMOSOME 19P; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE CLASSIFICATION; DNA DETERMINATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE SILENCING; GENETIC TRANSCRIPTION; GERMINAL CENTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN TISSUE; LARGE CELL LYMPHOMA; LYMPHOMA; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; WWOX GENE;

ADULT; BURKITT LYMPHOMA; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE DOSAGE; GENE EXPRESSION; HIV INFECTIONS; HUMANS; LYMPHOMA, AIDS-RELATED; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 77951682444     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181d3d9eb     Document Type: Article

References (50)

1. Krause J. AIDS-related non-Hodgkin's lymphomas. Microsc Res Tech. 2005;68:168-175.
2. Carbone A, Gloghini A. AIDS-related lymphomas: from pathogenesis to pathology. Br J Haematol. 2005;130:662-670.
3. Bonnet F, Chene G. Evolving epidemiology of malignancies in HIV. Curr Opin Oncol. 2008;20:534-540.
4. Silverberg MJ, Abrams DI. AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era. Curr Opin Oncol. 2007;19:446-451.
5. Barbaro G, Barbarini G. HIV infection and cancer in the era of highly active antiretroviral therapy (Review). Oncol Rep. 2007;17:1121-1126.
6. Biggar RJ, Chaturvedi AK, Goedert JJ, et al. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst. 2007;99:962-972.
7. Gaidano G, Carbone A, Dalla-Favera R. Pathogenesis of AIDS-related lymphomas: molecular and histogenetic heterogeneity. Am J Pathol. 1998; 152:623-630.
8. Carbone A, Gloghini A, Volpe R, et al. The pathology spectrum of AIDS-related non-Hodgkin's lymphoma [in Italian]. Pa t h o l o g i c a. 1998;90:763-770. (Pubitemid 128527398)
9. Neri A, Barriga F, Knowles DM, et al. Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal trans-locations in distinct pathogenetic forms of Burkitt lymphoma. Proc Natl Acad Sci USA. 1988;85:2748-2752.
10. Kramer MH, Hermans J, Wijburg E, et al. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood. 1998;92:3152-3162.
11. Knowles DM. Immunodeficiency-associated lymphoproliferative disorders. Mod Pathol. 1999;12:200-217.
12. Dave SS, Fu K, Wright GW, et al. Molecular diagnosis of Burkitt's lymphoma. N Engl J Med. 2006;354:2431-2442.
13. Hummel M, Bentink S, Berger H, et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med. 2006;354:2419-2430.
14. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403: 503-511.
15. Lenz G, Wright GW, Emre NC, et al. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci USA. 2008;105:13520-13525.
16. Lenz G, Wright G, Dave SS, et al. Stromal gene signatures in large-B-cell lymphomas. N Engl J Med. 2008;359:2313-2323.
17. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:1937-1947.
18. Wright G, Tan B, Rosenwald A, et al. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci USA. 2003;100:9991-9996.
19. Salaverria I, Zettl A, Bea S, et al. Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphoma. Haematologica. 2008;93:1327-1334.
20. Bentz M, Plesch A, Stilgenbauer S, et al. Minimal sizes of deletions detected by comparative genomic hybridization. Genes Chromosomes Cancer. 1998;21:172-175.
21. Ayers LW, Silver S, McGrath MS, et al. The AIDS and cancer specimen resource: role in HIV/AIDS scientific discovery. Infect Agent Cancer. 2007;2:7.
22. Ryan JL, Fan H, Glaser SL, et al. Epstein-Barr virus quantitation by realtime PCR targeting multiple gene segments: a novel approach to screen for the virus in paraffin-embedded tissue and plasma. J Mol Diagn. 2004;6: 378-385.
23. Fabbri M, Iliopoulos D, Trapasso F, et al. WWOX gene restoration prevents lung cancer growth in vitro and in vivo. Proc Natl Acad Sci USA. 2005;102:15611-15616.
24. Edgar R, Domrachev M, Lash AE. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30:207-210.
25. Simon R, Lam A, Li MC, et al. Analysis of gene expression data using BRB-array tools. Cancer Inform. 2007;3:11-17.
26. Carbone A. AIDS-related non-Hodgkin's lymphomas: from pathology and molecular pathogenesis to treatment. Hum Pathol. 2002;33:392-404.
27. Gaidano G, Ballerini P, Gong JZ, et al. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lympho-cytic leukemia. Proc Natl Acad Sci USA. 1991;88:5413-5417.
28. Lu P, Yang C, Guasparri I, et al. Early events of B-cell receptor signaling are not essential for the proliferation and viability of AIDS-related lymphoma. Leukemia. 2009;23:807-810.
29. Davies AJ, Rosenwald A, Wright G, et al. Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms. Br J Haematol. 2007;136:286-293.
30. Pietersma F, Piriou E, van Baarle D. Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immuno-compromised patients. Leuk Lymphoma. 2008;49:1028-1041.
31. Ballerini P, Gaidano G, Gong J, et al. Molecular pathogenesis of HIV-associated lymphomas. AIDS Res Hum Retroviruses. 1992;8:731-735.
32. Zunino A, Viaggi S, Ottaggio L, et al. Chromosomal aberrations evaluated by CGH, FISH and GTG-banding in a case of AIDS-related Burkitt's lymphoma. Haematologica. 2000;85:250-255.
33. Tiirikainen MI, Mullaney BP, Holly EA, et al. DNA copy number alterations in HIV-positive and HIV-negative patients with diffuse large-cell lymphomas. J Acquir Immune Defic Syndr. 2001;27:272-276.
34. Mullaney BP, Ng VL, Herndier BG, et al. Comparative genomic analyses of primary effusion lymphoma. Arch Pathol Lab Med. 2000;124:824-826.
35. Vaghefi P, Martin A, Prevot S, et al. Genomic imbalances in AIDS-related lymphomas: relation with tumoral Epstein-Barr virus status. AIDS. 2006;20: 2285-2291.
36. Michelotti EF, Tomonaga T, Krutzsch H, et al. Cellular nucleic acid binding protein regulates the CT element of the human c-myc protooncogene. J Biol Chem. 1995;270:9494-9499.
37. Tuomela S, Rautajoki KJ, Moulder R, et al. Identification of novel Stat6 regulated proteins in IL-4-treated mouse lymphocytes. Proteomics. 2009;9:1087-1098.
38. Sbrana I, Veroni F, Nieri M, et al. Chromosomal fragile sites FRA3B and FRA16D show correlated expression and association with failure of apoptosis in lymphocytes from patients with thyroid cancer. Genes Chromosomes Cancer. 2006;45:429-436.
39. Kameoka Y, Tagawa H, Tsuzuki S, et al. Contig array CGH at 3p14.2 points to the FRA3B/FHIT common fragile region as the target gene in diffuse large B-cell lymphoma. Oncogene. 2004;23:9148-9154.
40. Hussain A, Gutierrez MI, Timson G, et al. Frequent silencing of fragile histidine triad gene (FHIT) in Burkitt's lymphoma is associated with aberrant hypermethylation. Genes Chromosomes Cancer. 2004;41:321-329.
41. Chen PM, Yang MH, Hsiao LT, et al. Decreased FHIT protein expression correlates with a worse prognosis in patients with diffuse large B-cell lymphoma. Oncol Rep. 2004;11:349-356.
42. Yang J, Zhang W. WWOX tumor suppressor gene. Histol Histopathol. 2008;23:877-882.
43. Aqeilan RI, Pekarsky Y, Herrero JJ, et al. Functional association between Wwox tumor suppressor protein and p73, a p53 homolog. Proc Natl Acad Sci USA. 2004;101:4401-4406.
44. Ludes-Meyers JH, Kil H, Nunez MI, et al. WWOX hypomorphic mice display a higher incidence of B-cell lymphomas and develop testicular atrophy. Genes Chromosomes Cancer. 2007;46:1129-1136.
45. Pimenta FJ, Cordeiro GT, Pimenta LG, et al. Molecular alterations in the tumor suppressor gene WWOX in oral leukoplakias. Oral Oncol. 2008;44: 753-758.
46. Garcia JL, Hernandez JM, Gutierrez NC, et al. Abnormalities on 1q and 7q are associated with poor outcome in sporadic Burkitt's lymphoma. A cytogenetic and comparative genomic hybridization study. Leukemia. 2003;17:2016-2024.
47. Dreyling MH, Roulston D, Bohlander SK, et al. Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma. Genes Chromosomes Cancer. 1998;22:72-78.
48. Marce S, Balague O, Colomo L, et al. Lack of methylthioadenosine phosphorylase expression in mantle cell lymphoma is associated with shorter survival: implications for a potential targeted therapy. Clin Cancer Res. 2006;12:3754-3761.
49. Kawano R, Ohshima K, Karube K, et al. Prognostic significance of hepatocyte growth factor and c-MET expression in patients with diffuse large B-cell lymphoma. Br J Haematol. 2004;127:305-307.
50. Tran AH, Berger A, Wu GE, et al. Regulatory mechanisms in the differential expression of Hemokinin-1. Neuropeptides. 2009;43:1-12.